Innovacell
PrivateLast Round
Series D
Aug 21, 2025
Total Funding Raised
$80.9M
Momentum Score
25 /100
Company Overview
Innovacell is a biotechnology company that develops, produces, and markets cell therapies for treating fecal and urinary incontinence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Smart Manufacturing, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innovacell Comps
Public and private peers based on sector, stage, and business model.
Innovacell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Aug 21, 2025 | ||||
| Series C | Jul 21, 2022 | ||||
| Series A | Apr 26, 2012 |
Key People
Founding team and executive leadership
Innovacell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Happiness Capital | Series D |
| M&G Investments | Series D |
| Yokohama Capital Co., Ltd. | Series C |
| SBI Investment Co., Ltd. | Series D, Series C |
Innovacell Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innovacell's valuation, stock price, and market status.
